Endoscopic Ultrasound-Guided Ethanol Ablation for Aldosterone-Producing Adenoma

This is a prospective, single-center, single-arm study evaluating endoscopic ultrasound-guided ethanol ablation for left-sided aldosterone-producing adenoma. Eligible participants will receive the ablation procedure and be followed for safety, imaging response, biochemical remission, and clinical remission. The study is expected to enroll 30 participants.

NCT Number	NCT07700472
Lead Sponsor	Chongqing Medical University
Conditions	Primary Aldosteronism, Aldosterone-Producing Adenoma
Enrollment	30 participants
Start Date	2026-07-15
Primary Completion	2028-12-31 (estimated)
Study Completion	2029-07-15 (estimated)
Updated on ClinicalTrials.gov	2026-07-14